A Rat Model of Clinically Relevant Extracorporeal Circulation Develops Early Organ Dysfunctions.

cardiac surgery extracorporeal circulation patients cohort rat model transcriptomics

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
16 Apr 2023
Historique:
received: 06 02 2023
revised: 24 03 2023
accepted: 12 04 2023
medline: 1 5 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

In clinical practice, extracorporeal circulation (ECC) is associated with coagulopathy and inflammation, eventually leading to organ injuries without preventive systemic pharmacological treatment. Relevant models are needed to reproduce the pathophysiology observed in humans and preclinical tests. Rodent models are less expensive than large models but require adaptations and validated comparisons to clinics. This study aimed to develop a rat ECC model and to establish its clinical relevance. One hour of veno-arterial ECC or a sham procedure were achieved on mechanically ventilated rats after cannulations with a mean arterial pressure objective > 60 mmHg. Five hours post-surgery, the rats' behavior, plasmatic/blood biomarkers, and hemodynamics were measured. Blood biomarkers and transcriptomic changes were compared in 41 patients undergoing on-pump cardiac surgery. Five hours post-ECC, the rats presented hypotension, hyperlactatemia, and behavioral alterations. The same patterns of marker measurements (Lactate dehydrogenase, Creatinine kinase, ASAT, ALAT, and Troponin T) were observed in both rats and human patients. Transcriptome analyses showed similarity in both humans and rats in the biological processes involved in the ECC response. This new ECC rat model seems to resemble both ECC clinical procedures and the associated pathophysiology, but with early organ injury corresponding to a severe phenotype. Although the mechanisms at stake in the post-ECC pathophysiology of rats or humans need to be described, this new rat model appears to be a relevant and costless preclinical model of human ECC.

Identifiants

pubmed: 37108501
pii: ijms24087338
doi: 10.3390/ijms24087338
pmc: PMC10139167
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Agence Nationale de la Recherche
ID : 20-ASTC-0032-01-hErOiSmE/Agence Nationale de la Recherche
Organisme : Agence Nationale de la Recherche
ID : ANR-15-CE14-0004-02
Organisme : InFlectis BioScience
ID : CIFRE PhD
Organisme : Fédération française de cardiologie
ID : NA

Références

J Thorac Cardiovasc Surg. 2017 Jan;153(1):118-125.e1
pubmed: 27832832
Biology (Basel). 2021 Aug 24;10(9):
pubmed: 34571700
Int J Mol Sci. 2023 Feb 05;24(4):
pubmed: 36834573
J Thorac Cardiovasc Surg. 2011 Jun;141(6):1549-51
pubmed: 21397270
Organogenesis. 2011 Jan-Mar;7(1):42-9
pubmed: 21289481
Can J Anaesth. 2022 Mar;69(3):374-386
pubmed: 35014001
Interact Cardiovasc Thorac Surg. 2014 Oct;19(4):561-6
pubmed: 24987016
J Clin Med. 2021 Dec 08;10(24):
pubmed: 34945041
Crit Care. 2020 Jul 20;24(1):450
pubmed: 32690070
J Extra Corpor Technol. 2013 Sep;45(3):167-72
pubmed: 24303598
Perfusion. 2020 Nov;35(8):756-762
pubmed: 32098555
Circ Res. 2012 Jun 22;111(1):131-50
pubmed: 22595296
J Extra Corpor Technol. 2005 Mar;37(1):60-5
pubmed: 15804160
Ann Thorac Surg. 1993 Nov;56(5 Suppl):S92-6
pubmed: 8239845
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Artif Organs. 2013 Dec;37(12):1034-40
pubmed: 23865518
Semin Cardiothorac Vasc Anesth. 2014 Jun;18(2):161-76
pubmed: 24876231
Front Pediatr. 2019 Nov 26;7:492
pubmed: 31850289
J Clin Invest. 1927 Jun;4(2):273-93
pubmed: 16693758
Biology (Basel). 2020 Apr 20;9(4):
pubmed: 32326072
Perfusion. 2023 Feb 16;:2676591231157055
pubmed: 36794518
J Mol Cell Cardiol. 2018 Aug;121:190-204
pubmed: 30031815
Curr Opin Crit Care. 2009 Jun;15(3):234-8
pubmed: 19387339
Can J Anaesth. 2018 Aug;65(8):901-913
pubmed: 29696581
Cardiovasc Res. 2019 Nov 1;115(13):1838-1849
pubmed: 31243437
Basic Res Cardiol. 2007 Nov;102(6):508-17
pubmed: 17668258
Perfusion. 2023 May;38(4):807-817
pubmed: 35430909
J Thorac Cardiovasc Surg. 2017 Nov;154(5):1590-1598.e2
pubmed: 29042040
J Am Soc Nephrol. 2011 Sep;22(9):1748-57
pubmed: 21836143
Semin Cardiothorac Vasc Anesth. 2014 Jun;18(2):190-207
pubmed: 24682173
Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):46
pubmed: 31346840
Toxicol Lett. 2000 Apr 10;115(1):63-70
pubmed: 10817632
Bioinformatics. 2005 Jul 15;21(14):3105-13
pubmed: 15905280
BMC Cardiovasc Disord. 2017 May 15;17(1):123
pubmed: 28506218
ASAIO J. 2016 May-Jun;62(3):286-90
pubmed: 26809082
Anesthesiology. 2013 Sep;119(3):507-15
pubmed: 23835589
Indian J Crit Care Med. 2020 Apr;24(Suppl 3):S94-S97
pubmed: 32704211
Eur J Anaesthesiol. 2013 Aug;30(8):492-500
pubmed: 23344121
BMC Nephrol. 2016 Aug 02;17(1):109
pubmed: 27484681
Eur J Cardiothorac Surg. 2018 Jan 1;53(1):186-193
pubmed: 28977367

Auteurs

Antoine Persello (A)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.
InFlectis BioScience, 44200 Nantes, France.

Fouzia Souab (F)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.

Thomas Dupas (T)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.

Virginie Aillerie (V)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.

Edith Bigot (E)

Department of Biochemistry, CHU de Nantes, 44800 Nantes, France.

Manon Denis (M)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.

Angélique Erraud (A)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.

Thomas Pelé (T)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.

Angélique Blangy-Letheule (A)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.

Pierre Miniou (P)

InFlectis BioScience, 44200 Nantes, France.

Philippe Guedat (P)

InFlectis BioScience, 44200 Nantes, France.

Michel De Waard (M)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.

Emmanuelle Abgueguen (E)

InFlectis BioScience, 44200 Nantes, France.

Bertrand Rozec (B)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.

Benjamin Lauzier (B)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH